IMIsabella Manzur-Villalobos

Isabella Manzur-Villalobos

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Isabella Manzur-Villalobos has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    In silico evaluation of ginsenoside analogs as β and γ-secretase inhibitors in Alzheimer’s disease

    by Neyder Contreras-Puentes, Isabella Manzur-Villalobos, Samuel Vargas-Chico, Antistio Alviz-Amador

    Context: Alzheimer's disease is rising significantly and could reach alarming numbers in the coming decades. Therefore, diverse pathways are being explored to discover new therapies. Ginsenosides could reduce cellular damage, protect brain neurons, and cognitive function. Due to a lack of clarity regarding the potential inhibitory mechanisms of these compounds on pathophysiological pathways in β-amyloid development, bioinformatic analysis has been employed. Aims: To evaluate, through in silico analysis, analogs of ginsenosides as potential β- and γ-secretase inhibitors for Alzheimer's disease treatment. Methods: Ginsenoside analogs (798) were selected from the PubChem database and minimized using Open Babel Tools. β-secretase and γ-secretase were chosen from the Protein Data Bank database and prepared using AutoDockTools 1.5.7. Molecular docking for analogs and their co-crystallized molecules was executed using AutoDock-Vina. The interactions and binding types of complexes were analyzed. Molecular dynamics simulations were performed for analogs 146521791, 134688678, and Ginsenoside Rg1, as well as their co-crystallized molecules, using AMBER20 software. Results: In molecular docking, the molecules demonstrated superior binding affinity toward the β-secretase active site, with a score of 146521791, and for γ-secretase, it was 134688678. In molecular dynamics simulation, all β-secretase complexes showed structural stability (RMSD <2.5 Å), with high flexibility in residue position between 150-175, 312-325, and 362-375 (RMSF of 2-3 Å); for γ-secretase, the native protein shows less RMSD value variation in comparison to the other complexes, also all analog complexes showed the same movement variation in the γ-secretase residues with values between 1 and 3 Å. Conclusions: This suggests its therapeutic potential as an alternative Alzheimer's disease therapy, highlighting its ability to interfere with key enzymatic processes involved in the formation of amyloid peptide. This reveals its therapeutic potential as an alternative Alzheimer's disease therapy and highlights its ability to interfere with key enzymatic processes in the formation of amyloid peptides.

  • Open Access

    In silico study of dimethyltryptamine analogues against 5-HT1B receptor: Molecular docking, dynamic simulations and ADMET prediction

    by Neyder Contreras, Antistio Alvíz-Amador, Isabella Manzur-Villalobos

    Introduction: The 5-HT1B receptor has a potential role in various psychiatric disorders such as depression, anxiety, and post-traumatic stress disorder. The objective of this study was to perform docking and molecular dynamics simulation to evaluate at atomic level the behavior of N,N-dimethyltryptamine (DMT) on 5-HT1B receptor.Methods: In this study, initially, a search for DMT was performed using the PubChem database. Subsequently, molecular docking was executed using AutoDock Vina based in PyRx 0.8 with a 95% analogy. Additionally, ergotamine (ERG) and serotonin were used as control. Then, it ran a total of 100 ns molecular dynamics simulations on 5-HT1B bound with DMT, serotonin, 112814775, and ERG. Finally, pharmacokinetic prediction and IV acute toxicity for analogues and DMT were performed.Results: It was possible to show that 112814775 had the lowest binding energy with the receptor. In addition, 112814775 presented great conformational stability, low mobility, and stiffness compared to the control ligands: ERG, serotonin, and DMT subsequent dynamic analysis. With respect to the free energy calculation, contributions such as Van der Waals, electrostatics, and nonpolar interactions for all systems, were highlighted.Conclusion: 112814775 showed affinities with 5-HT1B receptor and evidenced notable behavior by molecular dynamic simulation according to root-mean-square deviation (RMSD), root-mean-square fluctuation (RMSF), solvent-accessible surface area (SASA), the radius of gyration, number of hydrogen bond, and free energy calculated. These results established the possible relevance of in-silico studies in search of DMT analogues against the 5-HT1B receptor, which may be associated with alterations such as depression and anxiety, and may become future study molecules for the treatment of this type of disorder.


  • Open Access

    LipStaT® Surgery, A Novel Technique for the Treatment of Gummy Smile: Case Report

    by Isabella Manzur Villalobos, Eilien Gisek Tovío Martínez, Eliana Marcela Guzmán Menco, Adel Martínez Martínez

    Introduction: The lip stabilization technique (LipStaT®) is a novel surgical approach for the management of gummy smile. It is an outpatient technique, minimally invasive, with low risk of morbidity and low incidence of complications. The goal of the technique is to reduce the excessive gingival display during smile. Objective: to describe the LipStaT® technique including its indications, preoperative evaluation, surgical approach and patient post procedure care instructions. Clinical Cases: the authors present two female patients, aged 20 and 31 years, with excessive gingival display (over 3mm) and with experiences of failures with other procedures. The LipStaT® technique allowed to achieve aesthetic, harmonic and functional results. Conclusion: The LipStaT® technique is a safe outpatient procedure that allows to obtain predictable results, which are well accepted by patients.

  • Open Access

    Manejo odontológico integral de paciente con antecedentes de ictus cerebral. Reporte de un caso

    by Maria Alejandra Puerta-Domínguez, Isabella Manzur-Villalobos, Ana Isabel Llera-Ladera, Héctor Juan Rodríguez-Casanovas, Antonio Díaz-Caballero

    Introducción: Ictus son un conjunto de patologías que afectan a los vasos sanguíneos que suministran la sangre al cerebro produciendo una alteración de la función de una determinada región de éste. El grupo de patologías son conocidas popularmente como embolias o accidentes cerebrovasculares (ACV) y se manifiestan súbitamente. Estos trastornos tienen en común su presentación brusca y suelen afectar a personas mayores, aunque también pueden presentarse en jóvenes. Objetivo: Dar a conocer a los profesionales de la salud las implicaciones y consecuencias que se deben tener en la práctica odontológica habitual y al momento de emplear tratamientos como la rehabilitación protésica fija o la colocación de implantes dentales en pacientes con cardiopatías, con la finalidad de evitar accidentes y prevenir hemorragias postoperatorias. Resultados: Se obtuvo resultados estéticos y funcionales satisfactorios en los tratamientos quirúrgicos y de rehabilitación bucal realizados al paciente. Conclusiones: Debido al riesgo de presentar accidentes cerebrovasculares normalmente están sometidos a terapia antiagregante plaquetaria, cuyo efecto secundario es la tendencia al sangrado; por ello es importante realizar un manejo multidisciplinario con el médico especialista al momento de emplear tratamientos quirúrgicos en este tipo de pacientes, con el fin de evitar complicaciones y obtener resultados adecuados.

  • Open Access

    Agrandamiento gingival farmacoinducido: Serie de casos

    by Isabella Manzur-Villalobos, Ivan Alejandro Díaz-Rengifo, Daniella Manzur-Villalobos, Antonio José Díaz-Caballero

    Introducción: El agrandamiento gingival (AG) es una condición benigna de la cavidad oral que se caracteriza por el crecimiento excesivo en masa y volumen de la gingiva. Esta lesión no es únicamente provocada por factores hereditarios ni de deficiente higiene oral, sino también por ingesta de medicamentos, entre los cuales se encuentran fármacos antihipertensivos, anticonvulsivantes e inmunosupresores. Objetivo: Sensibilizar respecto a la prevención o atención temprana en pacientes con patologías que ameritan el uso de antihipertensivos y anticonvulsivantes, conjuntamente con el odontólogo para tratar o evitar el agrandamiento gingival farmacioinducido (AGFI) Materiales y métodos: Se reporta una serie de casos clínicos de pacientes con agrandamiento gingival por distintos fármacos, entre los que se encuentran fenitoina, amlodipino y nifedipino; se aplicaron medidas de fase higiénica periodontal y gingivectomía para obtener mejores efectos. Resultados: Se obtuvieron resultados satisfactorios con una disminución considerable del AGFI. Conclusiones: Es importante el manejo integral en conjunto con el médico tratante para realizar seguimiento del fármaco que pueda encontrarse generando agrandamiento gingival. Emplear un abordaje inicial con estrategias de higiene periodontal, y en casos severos y como último recurso la intervención quirúrgica periodontal con gingivectomía y gingivoplastia.